The DGAT1 inhibitor Pradigastat Decreases Chylomicron Secretion and Prevents Postprandial Triglyceride Elevation in HumansCharles D. Meyers, B.N. Dardik, Rocheford Erik et al.|Journal of clinical lipidology|2013Cited by 24
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Michael H. Serrano‐Wu, Ricardo E. Chatelain et al.|Journal of Medicinal Chemistry|2017Cited by 18